T1	Participants 0 18	Gastric carcinoma:
T2	Participants 209 226	Gastric carcinoma
T3	Participants 289 312	diffuse and intestinal.
T4	Participants 639 699	85 biopsy samples from patients with gastric adenocarcinoma.
T5	Participants 704 771	control group consisted of 40 specimens from normal gastric mucosa.
